Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on September 9, 2025

September 9, 2025

First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton

GlobeNewswire

September 9, 2025

Hairy Cell Leukemia Foundation Celebrates 40th Anniversary

GlobeNewswire

September 9, 2025

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

GlobeNewswire

September 9, 2025

Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million

GlobeNewswire

September 9, 2025

Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome

GlobeNewswire

September 9, 2025

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

GlobeNewswire

September 9, 2025

Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

GlobeNewswire

September 9, 2025

CHO Plus Obtains U.S. Patent for Improved Production of Proteins Using Engineered Yeast Cells

GlobeNewswire

September 9, 2025

Cellectar Biosciences to Participate at Oppenheimer 3rd Annual Targeted Radiopharmaceutical Therapies in Oncology Summit

GlobeNewswire

September 9, 2025

NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. Acquisition; Gains Full Control of Global Manufacturing and Intellectual Property Assets

GlobeNewswire

September 9, 2025

HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program

GlobeNewswire

September 9, 2025

Hydrafacial Launches Inaugural Hydrafacial Advisory Councils & Ambassador Network to Fuel Next-Era Innovation and Growth

GlobeNewswire

September 9, 2025

Arrivent Presents the Final Analysis of Firmonertinib Monotherapy Data from Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2025 World Conference on Lung Cancer

GlobeNewswire

September 9, 2025

Hyperion DeFi Strengthens Leadership Team With Key Appointments to Accelerate DeFi Strategy

GlobeNewswire

September 9, 2025

Peer Leadership and Resilience Shine in Military Veteran Alpine Challenge

GlobeNewswire

September 9, 2025

Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

September 9, 2025

Enlivex Announces Issuance of New Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis

GlobeNewswire

September 9, 2025

Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer’s Disease Trial

GlobeNewswire

September 9, 2025

MAPS Board of Directors Names Betty Aldworth and Ismail Lourido Ali as Co-Executive Directors

GlobeNewswire

September 9, 2025

Xilio Therapeutics Announces Initiation of Phase 2 Trial for Efarindodekin Alfa (XTX301), a Tumor-Activated IL-12, and Achievement of $17.5 Million Development Milestone Under Exclusive License Agreement with Gilead

GlobeNewswire